Sinopharm Group Co Ltd - Company Profile

Powered by

All the data and insights you need on Sinopharm Group Co Ltd in one report.

  • Save hours of research time and resources with
    our up-to-date Sinopharm Group Co Ltd Strategy Report

  • Understand Sinopharm Group Co Ltd position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Sinopharm Group Co Ltd: Overview

Sinopharm Group Co Ltd (Sinopharm), a subsidiary of China National Pharmaceutical Group Corp, distributes pharmaceutical and healthcare products. The company provides distribution, logistics and other value-added services to foreign and domestic manufacturers and suppliers of pharmaceuticals, medical products and supplies, and other healthcare products. It serves hospitals, primary health service institutions, and retail drug stores. Sinopharm also manufactures and sells pharmaceuticals, chemical reagents, laboratory supplies, and carries out the development of pharmaceutical, medical services, and other health-related industries. The company manages a chain of medicine stores in China through direct operations and franchises to market pharmaceutical and healthcare products. Sinopharm is headquartered in Shanghai, China.

Gain a 360-degree view of Sinopharm Group Co Ltd and make more informed decisions for your business Gain a 360-degree view of Sinopharm Group Co Ltd and make more informed decisions for your business Find out more
Headquarters China

Address Sinopharm Group Building, No. 385, East, Shanghai, 200023


Telephone 86 21 23052299

No of Employees 113,362

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange 1099 (HKG)

Revenue (2022) $82.1B 6% (2022 vs 2021)

EPS XYZ

Net Income (2022) XYZ 9.9% (2022 vs 2021)

Market Cap* $8.3B

Net Profit Margin (2022) XYZ 3.4% (2022 vs 2021)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Sinopharm Group Co Ltd premium industry data and analytics

140+

Marketed Drugs

Understand Sinopharm Group Co Ltd’s commercialized product portfolio to stay one step ahead of the market.

70+

Clinical Trials

Determine Sinopharm Group Co Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

11+

Catalyst Calendar

Proactively evaluate Sinopharm Group Co Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

10+

Pipeline Drugs

Identify which of Sinopharm Group Co Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

2

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Products and Services

Products Services
Laboratory Supplies Retail Drug Stores
Chemical Reagents Pharmaceutical and Healthcare Products Distribution and Logistics
Medical Equipments
XYZ
XYZ
XYZ
Understand Sinopharm Group Co Ltd portfolio and identify potential areas for collaboration Understand Sinopharm Group Co Ltd portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Corporate Changes/Expansions In March, the company changed its address from 1st Floor, No.385 East Longhua Road, Huangpu District, Shanghai, the PRC to 1st and 11th to 15th Floors, No.385 East Longhua Road, Huangpu District, Shanghai, the PRC.
2023 Plans/Strategy In August, the company announced its plans to acquire Neuca.
2023 Contracts/Agreements In March, the company signed a joint venture with Elekta to increase the adoption of radiation therapy in lower-tier cities.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Sinopharm Group Co Ltd Shanghai Fosun Pharmaceutical (Group) Co Ltd China Resources Sanjiu Medical & Pharmaceutical Co Ltd Tasly Pharmaceutical Group Co Ltd Wai Yuen Tong Medicine Holdings Ltd
Headquarters China China China China Hong Kong
City Shanghai Shanghai Shenzhen Tianjin Hong Kong
State/Province Shanghai Shanghai Guangdong Tianjin -
No. of Employees 113,362 38,399 15,599 9,183 1,962
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Yu Qingming Chairman Executive Board 2021 59
Li Xiaojuan Chief Financial Officer Senior Management 2021 47
Liu Yong President; Director Executive Board 2017 54
Wu Yijian Secretary Senior Management 2019 53
Li Yang Vice President Senior Management 2018 45
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Sinopharm Group Co Ltd key executives to enhance your sales strategy Gain insight into Sinopharm Group Co Ltd key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward